Pfizer created phone line for doctors, saw increase in Nurtec sales, WSJ says
After learning doctors weren’t prescrbing its migraine drug Nurtec because they assumed insurance coverage would be a hassle, the company ...
Pfizer Inc. (PFE): Among Top Dividend Contenders List
Top 15. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other top dividend ...
Pfizer Has a New Playbook for Reviving Sales—and It’s Starting to Pay Off
The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...
Income Strategy: 2 Terrific Blue Chips Yielding 5-7%
Pfizer offers a 6.7% dividend yield, trading at a low valuation with resilient drug portfolio growth. Realty Income Corp. has ...
Rep. Julie Johnson Sells Off Shares of Pfizer Inc. (NYSE:PFE)
Representative Julie Johnson (D-Texas) recently sold shares of Pfizer Inc. (NYSE:PFE). In a filing disclosed on March 12th, the Representative disclosed that they had sold between $1,001 and $15,000 ...
Zacks Investment Research on MSN3d
Pfizer (PFE) Stock Moves -0.43%: What You Should Know
The most recent trading session ended with Pfizer (PFE) standing at $25.60, reflecting a -0.43% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily loss ...
Pfizer's Direct-To-Consumer Model Faces Scrutiny From US Senators (CORRECTED)
This article has been corrected to reflect that the senators asked UpScriptHealth to respond. In August 2024, Pfizer Inc ...
Guggenheim Reaffirms Their Buy Rating on Pfizer (PFE)
Guggenheim analyst Vamil Divan maintained a Buy rating on Pfizer (PFE – Research Report) yesterday. The company’s shares closed yesterday at ...
Is Pfizer Inc. (PFE) the Best Pharma Stock to Buy According to Hedge Funds?
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Rep. Jefferson Shreve Purchases Shares of Pfizer Inc. (NYSE:PFE)
Representative Jefferson Shreve (R-Indiana) recently bought shares of Pfizer Inc. (NYSE:PFE). In a filing disclosed on March ...
Pfizer Inc. stock underperforms Tuesday when compared to competitors
Shares of Pfizer Inc. PFE slid 2.44% to $25.99 Tuesday, on what proved to be an all-around poor trading session for the stock ...
Looking At Pfizer's Recent Unusual Options Activity
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is ...